374 related articles for article (PubMed ID: 16552784)
1. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS.
Sturiale L; Barone R; Palmigiano A; Ndosimao CN; Briones P; Adamowicz M; Jaeken J; Garozzo D
Proteomics; 2008 Sep; 8(18):3822-32. PubMed ID: 18712764
[TBL] [Abstract][Full Text] [Related]
4. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
[TBL] [Abstract][Full Text] [Related]
5. The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.
Mills K; Mills PB; Clayton PT; Mian N; Johnson AW; Winchester BG
Glycobiology; 2003 Feb; 13(2):73-85. PubMed ID: 12626422
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycosylation on the protein pattern in 2-D-gel electrophoresis.
Kleinert P; Kuster T; Arnold D; Jaeken J; Heizmann CW; Troxler H
Proteomics; 2007 Jan; 7(1):15-22. PubMed ID: 17152094
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx.
Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP
Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642
[TBL] [Abstract][Full Text] [Related]
8. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
9. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops.
Edwards M; McKenzie F; O'callaghan S; Somerset D; Woodford P; Spilsbury J; Fietz M; Fletcher J
Prenat Diagn; 2006 Oct; 26(10):985-8. PubMed ID: 16915591
[TBL] [Abstract][Full Text] [Related]
11. [Congenital disorders of glycosylation].
Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
Babovic-Vuksanovic D; O'Brien JF
Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
[TBL] [Abstract][Full Text] [Related]
13. Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease.
Pérez-Cerdá C; Quelhas D; Vega AI; Ecay J; Vilarinho L; Ugarte M
Clin Chem; 2008 Jan; 54(1):93-100. PubMed ID: 18024528
[TBL] [Abstract][Full Text] [Related]
14. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
Barone R; Sturiale L; Garozzo D
Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
[TBL] [Abstract][Full Text] [Related]
16. Detection of hypo-N-glycosylation using mass spectrometry of transferrin.
O'Brien JF; Lacey JM; Bergen HR
Curr Protoc Hum Genet; 2007 Jul; Chapter 17():Unit 17.4. PubMed ID: 18428410
[TBL] [Abstract][Full Text] [Related]
17. Differential susceptibility of transferrin glycoforms to chymotrypsin: a proteomics approach to the detection of carbohydrate-deficient transferrin.
Valmu L; Kalkkinen N; Husa A; Rye PD
Biochemistry; 2005 Dec; 44(49):16007-13. PubMed ID: 16331960
[TBL] [Abstract][Full Text] [Related]
18. Congenital disorders of glycosylation.
Jaeken J
Ann N Y Acad Sci; 2010 Dec; 1214():190-8. PubMed ID: 21175687
[TBL] [Abstract][Full Text] [Related]
19. Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital disorders of glycosylation.
Quintana E; Montero R; Casado M; Navarro-Sastre A; Vilaseca MA; Briones P; Artuch R
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2513-8. PubMed ID: 19608465
[TBL] [Abstract][Full Text] [Related]
20. Improvement of CDG diagnosis by combined examination of several glycoproteins.
Fang J; Peters V; Assmann B; Körner C; Hoffmann GF
J Inherit Metab Dis; 2004; 27(5):581-90. PubMed ID: 15669673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
